Monaco Asset Management SAM Sells 460,791 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Monaco Asset Management SAM cut its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 52.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 410,000 shares of the health services provider's stock after selling 460,791 shares during the period. Teladoc Health comprises about 0.5% of Monaco Asset Management SAM's investment portfolio, making the stock its 21st largest position. Monaco Asset Management SAM owned about 0.24% of Teladoc Health worth $3,727,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Versant Capital Management Inc grew its holdings in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health during the fourth quarter valued at $29,000. Lindbrook Capital LLC lifted its stake in Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after buying an additional 1,612 shares during the period. PNC Financial Services Group Inc. lifted its stake in Teladoc Health by 22.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock valued at $73,000 after buying an additional 1,439 shares during the period. Finally, KBC Group NV lifted its stake in Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider's stock valued at $80,000 after buying an additional 3,714 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Remove Ads

Teladoc Health Trading Down 5.3 %

Shares of TDOC stock traded down $0.47 on Tuesday, hitting $8.40. The company had a trading volume of 5,312,070 shares, compared to its average volume of 6,001,979. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $15.68. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock's 50-day moving average is $10.54 and its two-hundred day moving average is $9.73. The firm has a market cap of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Piper Sandler dropped their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Oppenheimer decreased their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research note on Friday, January 24th. Bank of America lifted their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research note on Wednesday, February 12th. Finally, The Goldman Sachs Group decreased their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Teladoc Health has an average rating of "Hold" and a consensus price target of $11.26.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.